Associations of elevated interleukin-6 and C-reactive protein levels with mortality in the elderly

American Journal of Medicine

Volumn 106, Issue 5, 1999, Pages 506-512

  Harris, Tamara B ^a   Ferrucci, Luigi ^b   Tracy, Russell P ^c   Corti, M Chiara ^d   Wacholder, Sholom ^e   Ettinger Jr , Walter H ^f   Heimovitz, Harley ^g   Cohen, Harvey J ^h   Wallace, Robert ⁱ  

^a NATIONAL INSTITUTE ON AGING   (United States)

^b National Research Institute   (Italy)

^c UNIVERSITY OF VERMONT   (United States)

^d UNIVERSITY OF PADOVA   (Italy)

^e NATIONAL CANCER INSTITUTE   (United States)

^f WAKE FOREST SCHOOL OF MEDICINE   (United States)

^g Sytel Inc   (United States)

^h DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

ⁱ UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; C REACTIVE PROTEIN; FIBRINOGEN; INTERLEUKIN 6;

AGED; ARTICLE; CARDIOVASCULAR DISEASE; CAUSE OF DEATH; CONTROLLED STUDY; FEMALE; GERIATRICS; HUMAN; HUMAN EXPERIMENT; MALE; MORTALITY; NORMAL HUMAN; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK ASSESSMENT; SMOKING;

AGED; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CAUSE OF DEATH; FEMALE; HUMANS; INFLAMMATION; INTERLEUKIN-6; IOWA; MALE; MORTALITY; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; RISK; RURAL HEALTH;

EID: 0033134682     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9343(99)00066-2     Document Type: Article

References (36)

1. Liuzzo G., Biasucci L.M., Gallimore J.R., et al. The prognostic value of C-reactive protein and serum amyloid A protein in severe unstable angina. NEJM. 331:1994;417-424.
2. European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group , Haverkate F., Thompson S.G., Pyke S.D.M., Gallimore J.R., Pepys M.B. Production of C-reactive protein and risk of coronary events in stable and unstable angina. Lancet. 349:1997;462-466.
3. Ridker P.M., Cushman M., Stampfer M.J., Tracy R.P., Hennekens C.H. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. NEJM. 336:1997;973-979.
4. MRFIT Research Group , Kuller L.H., Tracy R.P., Shaten J., Meilahn E.N. Relation of C-reactive protein and coronary heart disease in the MRFIT nested case-control study. Am J Epidemiol. 144:1996;537-547.
5. Tracy R.P., Lemaitre R.N., Psaty B.M., et al. Relationship of C-reactive protein to risk of cardiovascular disease in the elderly results from the Cardiovascular Health Study and the Rural Health Promotion Project . Arterioscler Throm Vasc Biol. 17:1997;1121-1127.
6. Thompson S.G., Kienast J., Puke S.D.M., Haverkate F., van de Loo J.C. Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group. NEJM. 332:1995;635-641.
7. Vallance P., Collier J., Bhagat K. Infection, inflammation, and infarction does acute endothelial dysfunction provide a link? Lancet. 349:1997;1391-1392.
8. Finnish Leukemia Group , Pelliniemi T.T., Irjala K., Mattila K., et al. Immunoreactive interleukin-6 and acute phase proteins as prognostic factors in multiple myeloma. Blood. 85:1995;765-771.
9. Moreland L.W., Baumgartner S.W., Schiff M.H., et al. Treatment of rheumatoid arthritis with a recombinant human tumor necrosis factor receptor (p75)-Fc fusion protein. NEJM. 337:1997;141-147.
10. Jilka R.L., Hangroc G., Girasole G., et al. Increased osteoclast development after estrogen loss mediation by interleukin-6 . Science. 257:1992;88-91.
11. Torre-Amione G., Kapadia S., Benedict C., Oral H., Young J.B., Mann D.L. Proinflammatory cytokine levels in patients with depressed left ventricular ejection fraction a report from the Studies of Left Ventricular Dysfunction (SOLVD) . J Am Coll Cardiol. 27:1996;1201-1206.
12. Pannen B.H.J., Robotham J.L. The acute-phase response. New Horizons. 3:1995;183-197.
13. Gauldie J., Richards C., Northemann W., Fey G., Baumann H. IFNB2/BSF2/IL-6 is the monocyte-derived HSF that regulates receptor-specific acute phase gene regulation in hepatocytes. Ann NY Acad Sci. 557:1989;46-59.
14. Kushner I., Jiang S.L., Zhang D., Lozanski G., Samols D. Do post-transcriptional mechanisms participate in induction of C-reactive protein and serum amyloid A by IL-6 and IL-1? Ann NY Acad Sci. 762:1995;102-107.
15. Mestries C., Kruithof E.K.O., Gascon M.P., Herodin F., Agay D., Ythier A. In vivo modulation of coagulation and fibrinolysis by recombinant glycosylated human interleukin-6 in baboons. Eur Cytokine Network. 5:1994;273-281.
16. Bataille R., Klein B. C-reactive protein levels as a direct indicator of interleukin-6 levels in humans in vivo. Arthritis Rheum. 35:1992;982-983.
17. Lu Z.Y., Brailly H., Wijdenes J., Bataille R., Rossi J.F., Klein B. Measurement of whole body interleukin-6 (IL-6) production prediction of the efficacy of anti-IL-6 treatments . Blood. 86:1995;3123-3131.
18. Cornoni-Huntley J., Ostfeld A.M., Taylor J.A., et al. Established populations for epidemiologic studies of the elderly study design and methodology . Aging. 5:1993;27-37.
19. Macy E.M., Hayes T.E., Tracy R.P. Variability in the measurement of C-reactive protein in healthy subjects implications for reference intervals and epidemiological applications . Clin Chem. 43:1997;52-58.
20. Geffken D., Keating F., Kennedy M., Cornell E., Bovill E., Tracy R. The measurement of fibrinogen in population-based research studies on instrumentation and methodology . Arch Pathol Lab Med. 118:1994;1106-1109.
21. Preston DL, Lubin JH, Pierce DA, McConney ME. Epicure User's Guide. Seattle, WA: HiroSoft International Corporation, 1993.
22. Prentice R.L. A case-cohort design for epidemiologic cohort studies and disease prevention trials. Biometrika. 73:1986;1-11.
23. Papanicolaou D.A. The pathophysiologic roles of interleukin-6 in human disease. Ann Intern Med. 128:1998;127-137.
24. Van der Poll T., Levi M., Hack C.E., et al. Elimination of interleukin-6 attenuates coagulation activation in experimental endotoxemia in chimpanzees. J Exp Med. 179:1994;1253-1259.
25. Cermak J., Key N.S., Bach R.R., Balla J., Jacob H.S., Vercellotti G.M. C-reactive protein induces human peripheral blood monocytes to synthesize tissue factor. Blood. 82:1993;513-520.
26. Cohen H.J., Pieper C.F., Harris T.B., Rao K.M.K., Currie M.S. The association of plasma IL-6 levels with functional disability in community-dwelling elderly. J Gerontol Med Sci. 52A:1997;M201-M208.
27. Danesh J., Collins R., Peto R. Chronic infections and coronary heart disease is there a link? Lancet. 350:1997;430-436.
28. Baeuerle P.A., Rupec R.A., Pahl H.L. Reactive oxygen intermediates as second messengers of a general pathogen response. Path Biol. 44:1996;29-35.
29. Tilg H., Dinarello C.A., Mier J.W. IL-6 and APPs anti-inflammatory and immunosuppressive mediators . Immun Today. 18:1997;428-432.
30. Xing A., Gauldie J., Cox G., et al. IL-6 is an anti-inflammatory cytokine required for controlling local or systemic acute inflammatory response. J Clin Invest. 101:1998;311-320.
31. Van Zaanen HC, Koopmans R.P., Aarden L.A., et al. Endogenous interleukin-6 production in multiple myeloma patients treated with chimeric monoclonal anti-IL6 antibodies indicates the existence of a positive feed-back loop. J Clin Invest. 98:1996;1141-1148.
32. DeRijk R., Michelson D., Karp B., et al. Exercise and circadian rhythm-induced variations in plasma cortisol differentially regulate interleukin-1, IL-6 and tumor necrosis factor-production in humans high sensitivity of TNF-α and resistance of IL-6 . J Clin Endocrinol Metab. 87:1997;2182-2191.
33. Sothern R.B., Roitman-Johnson B., Kanabrocki E.L., et al. Circadian characteristics of IL-6 in blood and urine of clinically healthy men. In Vivo. 9:1995;331-339.
34. Rao K.M.K., Pieper C.S., Currie M.S., Cohen H.J. Variability of plasma IL-6 and crosslinked fibrin dimers over time in community-dwelling elderly subjects. Am J Clin Pathol. 102:1994;802-805.
35. Mendenhall M.A., Patel P., Ballam L., Strachan D., Northfield T.C. C reactive protein and its relationship to cardiovascular risk factors a population-based cross sectional study . BMJ. 312:1996;1061-1065.
36. Tracy R.P., Macy E.M., Bovill E.G., et al. Lifetime smoking exposure affects the association of C-reactive protein with cardiovascular disease risk factors and subclinical disease in healthy elderly subjects. Arterioscler Thromb Vasc Biol. 17:1997;2167-2176.